methamphetamine abuse Clinical Trials

8 recruitingLast updated: May 11, 2026

There are 8 actively recruiting methamphetamine abuse clinical trials across 2 countries. Studies span Phase 2, Not Applicable, Phase 3. Top locations include Dallas, Texas, United States, Portland, Oregon, United States, Montreal, Quebec, Canada. Updated daily from ClinicalTrials.gov.


methamphetamine abuse Trials at a Glance

8 actively recruiting trials for methamphetamine abuse are listed on ClinicalTrialsFinder across 6 cities in 2 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Dallas, Portland, and Montreal. Lead sponsors running methamphetamine abuse studies include Centre hospitalier de l'Université de Montréal (CHUM), Laureate Institute for Brain Research, Inc., and Clear Scientific, Inc..

Browse methamphetamine abuse trials by phase

Treatments under study

About methamphetamine abuse Clinical Trials

Looking for clinical trials for methamphetamine abuse? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new methamphetamine abuse trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about methamphetamine abuse clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2

Ketamine for Methamphetamine Use Disorder

methamphetamine abuseSubstance Use DisordersSubstance Use
University of Texas Southwestern Medical Center120 enrolled5 locationsNCT06496750
Recruiting
Phase 2

Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder

methamphetamine abuseSubstance AbuseMethamphetamine Dependence+2 more
Centre hospitalier de l'Université de Montréal (CHUM)80 enrolled1 locationNCT06788587
Recruiting
Phase 3

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

methamphetamine abuseMethamphetamine Dependence
National Institute on Drug Abuse (NIDA)360 enrolled11 locationsNCT06233799
Recruiting
Not Applicable

Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives

methamphetamine abuseOpioid UseOpioid-use Disorder+4 more
Wake Forest University Health Sciences600 enrolled2 locationsNCT04927143
Recruiting
Phase 2

Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users

methamphetamine abuseMethamphetamine DependenceAddiction+1 more
Centre hospitalier de l'Université de Montréal (CHUM)440 enrolled4 locationsNCT05854667
Recruiting
Phase 2

A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine

methamphetamine abuseMethamphetamine DisordersMethamphetamine Intoxication
Clear Scientific, Inc.40 enrolled1 locationNCT06721494
Recruiting
Not Applicable

Mood and Decision-making in Methamphetamine Use Disorder

methamphetamine abuse
Laureate Institute for Brain Research, Inc.80 enrolled1 locationNCT06410196
Recruiting
Not Applicable

rTMS for Craving in Methamphetamine Use Disorder

methamphetamine abuseSubstance Use DisordersTranscranial Magnetic Stimulation+3 more
Oregon Health and Science University50 enrolled1 locationNCT03470480